O
Otto Simonsson
Researcher in Clinical Neuroscience at Karolinska Institute
Key Impact
Explores the psychiatric risks and benefits of psychedelic use, focusing on genetic and environmental factors.
Background & Research
Otto Simonsson is a Swedish researcher whose work examines the prevalence of mental health outcomes associated with naturalistic psychedelic use. He investigates how individual factors, such as a family history of mental illness, influence the response to psychedelics. His research aims to provide a more nuanced understanding of safety and risk profiles for psychedelic medicine in diverse populations.
Focus Areas
Psychiatric RisksGenetic CorrelatesNaturalistic UseEpidemiology